MNKD Reiterated by Cantor Fitzgerald -- Price Target Maintained at $8.00

gurufocus.com · 2026-10-20

MannKind Corp (MNKD) Analyst Rating Update On October 19, 2023, Cantor Fitzgerald maintained an Overweight rating for MannKind (MNKD). The price target remai

TickrTrends take: Cantor Fitzgerald's maintained price target of $8 represents analyst confidence in MNKD's current trajectory within the Healthcare sector. Given TickrTrends' concurrent undervalued assessment, the reiteration suggests the market may not yet have fully priced in the company's potential, creating a point of interest for investors focused on valuation metrics. A valuation-focused reader should monitor whether MNKD moves toward the $8 target, as this would help validate or challenge the undervalued positioning.

Read the full story at gurufocus.com →